Table III.
Comparison of serum CA125, VEGF and OPN levels of patients between OCG and the control group (mean ± SD).
| Group | Cases | CA125 (U/ml) | t-test | P-value | VEGF (pg/ml) | t-test | P-value | OPN (ng/ml) | t-test | P-value |
|---|---|---|---|---|---|---|---|---|---|---|
| MTG | 106 | 169.82±26.38a | 5.981 | 0.001 | 679.62±57.83a | 10.288 | <0.001 | 216.87±34.95a | 5.645 | 0.001 |
| BCG | 50 | 22.83±7.29 | 123.54±16.68 | 36.62±8.73 |
a
P<0.01, compared with BCG. CA125, carbohydrate antigen 125; VEGF, vascular endothelial growth factor; OPN, osteopontin; OCG, ovarian cancer group; MTG, malignant tumor group; BCG, benign control group.